ARTICLE | Emerging Company Profile

Shorla: making women’s and children’s cancer drugs more accessible

Ireland’s Shorla provides new formulations and addresses supply shortages of small molecules to treat women’s and pediatric cancers

December 22, 2021 1:57 AM UTC

By improving the manufacturing and formulation of established therapies, Shorla aims to increase patient access and compliance for small molecules targeting women’s and children’s cancers.

Shorla Pharma Ltd. co-founders Sharon Cunningham and Orlaith Ryan met while working together at EirGen Pharma Ltd., which was acquired by Opko Health Inc. (NASDAQ:OPK; Tel Aviv:OPK) in 2015, and connected over their shared concern about the under-treatment of women’s and children’s cancers. ...